Black Diamond Therapeutics, Inc. Ratios

Ratios Dec2018 Dec2019 Dec2020 Dec2021
Profitability
EBT Margin 6,553,000.00%
EBIT Margin 6,957,000.00%
EBITDA Margin 6,664,000.00%
Operating Margin 6,957,000.00%
Net Margin 6,553,000.00%
FCF Margin 5,228,800.00%
Efficiency
Assets Average 105.06M243.98M
Equity Average -31.35M130.30M
Invested Capital -13.84M-47.16M307.76M
Asset Utilization Ratio 0.00
Leverage & Solvency
Interest Coverage Ratio -0.07M
Debt to Equity -0.11
Debt Ratio 0.03
Equity Ratio -0.30-0.300.93
Times Interest Earned -0.07M
Valuation
Enterprise Value -51.66M-154.67M838.59M193.10M
Market Capitalization 1,153.66M193.10M
Return Ratios
Return on Capital Employed -0.29%-0.30%
Return on Assets -0.27%-0.27%
Return on Equity 0.92%-0.50%